Patents Assigned to Interface Biomedical Laboratories Corp.
  • Patent number: 5344425
    Abstract: An anti-turbulent, anti-thrombogenic intravascular stent of a helically shaped titanium or aluminum strip having an airfoil on internal surfaces thereof for increasing blood flow through the stent without creating areas of stagnant or turbulent flow therein. Also, a method for cleaning the stent for optimum performance in the intended application, and the stents which are cleaned by the process, and novel devices for introducing the stents of the invention into the body of a patient.
    Type: Grant
    Filed: February 6, 1992
    Date of Patent: September 6, 1994
    Assignee: Interface Biomedical Laboratories, Corp.
    Inventor: Philip N. Sawyer
  • Patent number: 5156613
    Abstract: A method of joining or reconstructing biological tissue which comprises applying optical energy to the biological tissue while providing a collagen filler material thereto; denaturing the collagen filler material and biological tissue with the optical energy to cause joining of the collagen filler material and biological tissue, thus joining or reconstructing such tissue.
    Type: Grant
    Filed: February 13, 1991
    Date of Patent: October 20, 1992
    Assignee: Interface Biomedical Laboratories Corp.
    Inventor: Philip N. Sawyer
  • Patent number: 5108417
    Abstract: An anti-turbulent, anti-thrombogenic intravascular stent of a helically shaped titanium or aluminum strip having an airfoil on internal surfaces thereof for increasing blood flow velocity through the stent without creating areas of stagnant or turbulent flow therein.
    Type: Grant
    Filed: September 14, 1990
    Date of Patent: April 28, 1992
    Assignee: Interface Biomedical Laboratories Corp.
    Inventor: Philip N. Sawyer
  • Patent number: 5098406
    Abstract: A fluid flow control device of tubular means having fluid input means and fluid output means connected by a bore constituting a flow channel, means for maintaining the bore in a normally closed position, the bore being forcible to an open position in response to insertion of a medical device into the fluid input means and past the maintaining means, the maintaining means being constructed and arranged to return the bore to the closed position when the medical device is removed therefrom; and means for prevention of fluid reflux or blood from the fluid output means toward the fluid input means when the bore is in the open position.
    Type: Grant
    Filed: November 1, 1990
    Date of Patent: March 24, 1992
    Assignee: Interface Biomedical Laboratories Corp.
    Inventor: Philip N. Sawyer
  • Patent number: 4883461
    Abstract: Methods for preventing needle-stick injuries to healthcare workers during intravenous or intra-arterial procedures as well as for preventing catheter-contamination and blood clotting within the tip of the catheter. Also, novel fluid directing means and catheters which include integral fluid flow control means for use in these methods.
    Type: Grant
    Filed: November 10, 1988
    Date of Patent: November 28, 1989
    Assignee: Interface Biomedical Laboratories Corp.
    Inventor: Philip N. Sawyer
  • Patent number: 4784644
    Abstract: A method for preventing the introduction of air into the vascular system of a patient during intravenous or intra-arterial procedures, as well as for preventing the reflux of fluids into the body of a patient. Also, novel fluid directing means and catheters which include integral or attached fluid flow control means for use in this method.
    Type: Grant
    Filed: May 15, 1987
    Date of Patent: November 15, 1988
    Assignee: Interface Biomedical Laboratories Corp.
    Inventors: Philip N. Sawyer, Joseph F. Fitzgerald, Lester F. Miller
  • Patent number: 4738849
    Abstract: A composite medical article comprising a porous body, a first layer of a medicinal substance and a second layer of a medicinal substance. A method for forming a composite medical article comprising saturating a porous substrate so as to incorporate a first medicinal substance therein, preparing a coating therefor comprising a second medicinal substance with at least a portion thereof in liquid phase, affixing an onlay of the coating to the material by freezing the liquid portion of the coating to the material to form an onlaid composite medical article and drying the article. The medicinal substances may comprise either a hemostatic agent or a medicament.
    Type: Grant
    Filed: December 22, 1986
    Date of Patent: April 19, 1988
    Assignee: Interface Biomedical Laboratories Corp.
    Inventor: Philip N. Sawyer
  • Patent number: 4167045
    Abstract: A prosthesis suitable for implantation in a bloody environment. The prosthesis includes a surface material adapted for exhibiting a regular and periodic surface charge characteristic in the bloody environment. A prosthesis means supports the surface material and is adapted to perform a prosthetic function in the bloody environment. In cases where cross-linking is desired and the surface material cannot cross-link with the substrate material, an adaptive material is provided which cross-links both to the surface material and to the material of the prosthesis. In one type of prosthesis, the surface material is aluminized. In another type of prosthesis, acrylamide is applied to the prosthesis. In still another type of prosthesis, agar is applied to the prosthesis in conjunction with gelatin. In another type of prosthesis, albumin is applied to the prosthesis.
    Type: Grant
    Filed: August 26, 1977
    Date of Patent: September 11, 1979
    Assignee: Interface Biomedical Laboratories Corp.
    Inventor: Philip N. Sawyer